• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞色素P4503A4的常见等位基因变体及其在不同人群中的患病率。

Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.

作者信息

Lamba Jatinder K, Lin Yvonne S, Thummel Kenneth, Daly Ann, Watkins Paul B, Strom Stephen, Zhang Jiong, Schuetz Erin G

机构信息

Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

出版信息

Pharmacogenetics. 2002 Mar;12(2):121-32. doi: 10.1097/00008571-200203000-00006.

DOI:10.1097/00008571-200203000-00006
PMID:11875366
Abstract

Marked interindividual variability in expression of CYP3A4 influences the disposition of many endo- and xenobiotics, including the metabolism of steroids, environmental toxins and therapeutically useful drugs. The present study was designed to determine the genetic basis of CYP3A4 variability. We analysed DNA from 82 individuals with known CYP3A4 phenotype including 53 Caucasians and 21 African-American liver donors, seven individuals who were outliers in CYP3A4 metabolism and five individuals in a family of a poor nifedipine metabolizer. In addition, we analysed DNA from the eight person DNA Polymorphism Discovery Resource subset (Coriell Institute) and 89 individuals representing nine ethnic groups. Five non-synonymous mutations in the coding region of CYP3A4 were observed. CYP3A414 (T44C) in exon 1 resulted in an L15P change; CYP3A415 (G14387A) in exon 6 resulted in a R162Q substitution; CYP3A410 (G14422C) in exon 6 resulted in a D174H substitution; CYP3A416 (C15721G) in exon 7 resulted in a T185S amino acid substitution; and CYP3A4*12 (C22002T) in exon 11 resulted in a L373F change in the CYP3A4 protein. An additional six single nucleotide polymorphisms (SNPs) in the 5'-UTR, 13 SNPs in the introns and three SNPs in the 3'-UTR were observed. Extensive population differences were observed in the frequencies of various CYP3A4 alleles. None of the 28 CYP3A4 SNPs identified in CYP3A4 phenotyped persons (most individuals being heterozygous for any CYP3A4 variant) was associated with low hepatic CYP3A4 protein expression or low CYP3A4 activity in vivo.

摘要

CYP3A4表达存在显著的个体间差异,这会影响许多内源性和外源性物质的处置,包括类固醇、环境毒素和治疗性药物的代谢。本研究旨在确定CYP3A4变异性的遗传基础。我们分析了82名已知CYP3A4表型个体的DNA,其中包括53名白种人和21名非裔美国肝脏供体、7名CYP3A4代谢异常个体以及硝苯地平代谢不良者家族中的5名个体。此外,我们还分析了来自八人DNA多态性发现资源子集(科里尔研究所)的DNA以及代表九个种族群体的89名个体的DNA。在CYP3A4编码区观察到五个非同义突变。外显子1中的CYP3A414(T44C)导致L15P改变;外显子6中的CYP3A415(G14387A)导致R162Q替代;外显子6中的CYP3A410(G14422C)导致D174H替代;外显子7中的CYP3A416(C15721G)导致T185S氨基酸替代;外显子11中的CYP3A4*12(C22002T)导致CYP3A4蛋白中的L373F改变。在5'-UTR中还观察到另外六个单核苷酸多态性(SNP)、内含子中的13个SNP以及3'-UTR中的三个SNP。在各种CYP3A4等位基因的频率上观察到广泛的人群差异。在CYP3A4表型个体中鉴定出的28个CYP3A4 SNP(大多数个体对任何CYP3A4变体均为杂合子)均与肝脏CYP3A4蛋白低表达或体内CYP3A4低活性无关。

相似文献

1
Common allelic variants of cytochrome P4503A4 and their prevalence in different populations.细胞色素P4503A4的常见等位基因变体及其在不同人群中的患病率。
Pharmacogenetics. 2002 Mar;12(2):121-32. doi: 10.1097/00008571-200203000-00006.
2
Recombinant CYP3A4*17 is defective in metabolizing the hypertensive drug nifedipine, and the CYP3A4*17 allele may occur on the same chromosome as CYP3A5*3, representing a new putative defective CYP3A haplotype.重组CYP3A4*17在代谢高血压药物硝苯地平方面存在缺陷,且CYP3A4*17等位基因可能与CYP3A5*3出现在同一条染色体上,代表一种新的假定有缺陷的CYP3A单倍型。
J Pharmacol Exp Ther. 2005 Apr;313(1):302-9. doi: 10.1124/jpet.104.078758. Epub 2005 Jan 5.
3
Identification of variants of CYP3A4 and characterization of their abilities to metabolize testosterone and chlorpyrifos.细胞色素P450 3A4(CYP3A4)变体的鉴定及其代谢睾酮和毒死蜱能力的表征。
J Pharmacol Exp Ther. 2001 Dec;299(3):825-31.
4
Novel mutations of CYP3A4 in Chinese.中国人中CYP3A4的新型突变
Drug Metab Dispos. 2001 Mar;29(3):268-73.
5
The human pregnane X receptor: genomic structure and identification and functional characterization of natural allelic variants.人类孕烷X受体:基因组结构以及天然等位基因变体的鉴定与功能表征
Pharmacogenetics. 2001 Oct;11(7):555-72. doi: 10.1097/00008571-200110000-00003.
6
Mutation analysis of the human CYP3A4 gene 5' regulatory region: population screening using non-radioactive SSCP.人类CYP3A4基因5'调控区的突变分析:使用非放射性单链构象多态性的群体筛查。
Mutat Res. 2002 Mar 20;500(1-2):103-10. doi: 10.1016/s0027-5107(01)00305-0.
7
CYP3A5*3 and CYP3A4*18 single nucleotide polymorphisms in a Chinese population.中国人群中CYP3A5*3和CYP3A4*18单核苷酸多态性
Clin Chim Acta. 2005 Mar;353(1-2):187-92. doi: 10.1016/j.cccn.2004.11.005.
8
Identification and functional characterization of eight CYP3A4 protein variants.8种CYP3A4蛋白变体的鉴定及功能特性分析
Pharmacogenetics. 2001 Jul;11(5):447-58. doi: 10.1097/00008571-200107000-00008.
9
CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity.CYP3A4酶活性低的白人个体中的CYP3A4变异等位基因。
Clin Pharmacol Ther. 2002 Mar;71(3):196-204. doi: 10.1067/mcp.2002.121371.
10
Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region.CYP3A4肝脏表达的个体差异:与5'-上游调控区基因多态性的关系。
Biochem Biophys Res Commun. 1999 May 27;259(1):201-5. doi: 10.1006/bbrc.1999.0752.

引用本文的文献

1
Natural Polymorphic Variants in the CYP450 Superfamily: A Review of Potential Structural Mechanisms and Functional Consequences.细胞色素P450超家族中的天然多态性变体:潜在结构机制与功能后果综述
Int J Mol Sci. 2025 Aug 12;26(16):7797. doi: 10.3390/ijms26167797.
2
Inflammation altered correlation between CYP2C19 genotype and CYP2C19 activity in patients receiving voriconazole.炎症改变了接受伏立康唑治疗的患者中 CYP2C19 基因型和 CYP2C19 活性之间的相关性。
Clin Transl Sci. 2024 Jul;17(7):e13887. doi: 10.1111/cts.13887.
3
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene-drug interaction between CYP2D6, CYP3A4 and CYP1A2 and antipsychotics.
荷兰药物基因组学工作组(DPWG)关于CYP2D6、CYP3A4和CYP1A2与抗精神病药物之间基因-药物相互作用的指南。
Eur J Hum Genet. 2024 Mar;32(3):278-285. doi: 10.1038/s41431-023-01347-3. Epub 2023 Mar 31.
4
Functional evaluation of cyclosporine metabolism by CYP3A4 variants and potential drug interactions.CYP3A4 变体对环孢素代谢的功能评估及潜在药物相互作用
Front Pharmacol. 2023 Jan 6;13:1044817. doi: 10.3389/fphar.2022.1044817. eCollection 2022.
5
Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5.新型远端增强子中的调控变异可调节 CYP3A4 和 CYP3A5 的表达。
Clin Transl Sci. 2022 Nov;15(11):2720-2731. doi: 10.1111/cts.13398. Epub 2022 Sep 20.
6
Interplay of Vitamin D and CYP3A4 Polymorphisms in Endocrine Disorders and Cancer.维生素 D 与 CYP3A4 多态性在内分泌疾病和癌症中的相互作用。
Endocrinol Metab (Seoul). 2022 Jun;37(3):392-407. doi: 10.3803/EnM.2021.1349. Epub 2022 Jun 3.
7
Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib.ABCB1 和 ABCG2 多态性对 abemaciclib 药代动力学的影响。
Eur J Clin Pharmacol. 2022 Aug;78(8):1239-1247. doi: 10.1007/s00228-022-03331-0. Epub 2022 May 9.
8
Comparison of one-week versus three-week paclitaxel for advanced pan-carcinomas: systematic review and meta-analysis.一周方案与三周方案治疗晚期泛癌种紫杉醇类药物比较的系统评价和荟萃分析。
Aging (Albany NY). 2022 Feb 26;14(4):1959-1982. doi: 10.18632/aging.203919.
9
Genotyping in Clinical Practice: Ready for Implementation?临床实践中的基因分型:准备好实施了吗?
Front Genet. 2021 Jul 8;12:711943. doi: 10.3389/fgene.2021.711943. eCollection 2021.
10
Sources of Interindividual Variability.个体间差异的来源。
Methods Mol Biol. 2021;2342:481-550. doi: 10.1007/978-1-0716-1554-6_17.